Blood Pressure Stabilization and Vascular Function Enhancement with Hydrogen-Oxygen Nanobubble Therapy in Stage 1 Hypertension: A Case Report
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background. Hypertension is a leading global health burden, with challenges in conventional therapies including poor adherence and adverse effects. Hydrogen-Oxygen Nanobubble (NB-HHO) therapy combines the antioxidant and anti-inflammatory effects of molecular hydrogen (H₂) with enhanced delivery via nanobubble technology, offering a novel non-pharmacological approach. Case presentation. A 41-year-old male with a 10-year history of untreated Stage 1 hypertension (baseline blood pressure: 141/95 mmHg) received 12 sessions of intravenous NB-HHO therapy (5–20 mL) with supplemental oxygen over four weeks. Blood pressure progressively decreased, stabilizing at 120/80 mmHg by session 10. Heart rate remained stable, and no adverse events were reported. Discussion. NB-HHO therapy likely achieved blood pressure control through ROS scavenging, enhanced antioxidant defenses, and improved endothelial function. Oxygen inhalation may have further supported mitochondrial bioenergetics and autonomic balance. Conclusion. NB-HHO therapy was safe and effective in normalizing blood pressure without pharmacotherapy in this case. Larger trials are needed to validate these findings and clarify mechanisms.